The Queen’s SARS CoV-2/COVID-19 research funding competition is a $200,000 Vice-Principal (Research) initiative to fund and support research projects that will contribute to urgent efforts to accelerate the development, testing and implementation of medical or social countermeasures to mitigate the rapid spread of the SARS CoV-2 virus and its negative consequences on people and communities in Canada and globally.
To a large extent this opportunity mirrors the recent SARS CoV-2/COVID-19 funding opportunity available through CIHR and will support research across all disciplines: health sciences; natural sciences and engineering; and social sciences and humanities.
$10,000-$50,000 per project (total available is $200,000)
- April 17, 2020 – Full applications due
- April 27, 2020 – Decisions released
- October 31, 2020 – Project Spending Deadline
- May 15, 2020 – Full applications due
- May 25, 2020 – Decisions released
- December 31, 2020 – Project Spending Deadline
This competition will support research across all disciplines.
Based on recommendations from the World Health Organization and per the, now closed, CIHR-led competition (plus several additions shown in contrasting black font
Funded Projects will strike a balance between Medical and Social/Policy countermeasures research, based on the number of proposals received in each category.
All expenses directly related to the research are eligible with the exception of equipment purchases and teaching release allowance.
The Principal Investigator must be Queen’s tenured, tenure-track, or clinical faculty with protected research time.
Co-investigators must hold a faculty appointment at Queen’s.
Other team members may be Queen’s tenured, tenure-track, or clinical faculty with protected research time, adjuncts, research associates, students, post-doctoral fellows, etc.
Two criteria are assessed as pass/fail:
- The proposed project is aligned with the objective of the competition.
- The proposed project is aligned with the selected countermeasure(s).
An additional four criteria are assessed equally (25% weight each):
- Effectiveness of the proposed approach (i.e., extent to which the approach is likely to lead to meeting the objectives of the proposed research).
- Ability of the project team to carry out the proposed research.
- Ability of the project team to marshal sufficient resources, including infrastructure and the funding from this competition, to successfully carry out the proposed research in the required timeframe.
- Potential impact of the proposed project.
A panel of reviewers from Queen’s will be engaged for each category of research (Medical Countermeasures and Social/Policy Countermeasures).
Each application will be assessed by 3 reviewers.
Projects receiving a Fail from all three reviewers on Criteria 1 and/or 2 will not be funded.
Reviewers will provide a score for each of the remaining 4 criteria. Based on assessments from the three reviewers, each application will be given an average score (criteria 3-6) and will be ranked accordingly.
Reviewers will be asked to comment on whether sex and gender and other identity factors have been adequately considered.
An expert will comment on whether engagement with Indigenous populations has been adequately considered, where applicable.
All adjudication information will be provided to the Vice Principal Research who will convene two panels (Medical and Social/Policy) to make the final decisions.
The application form is available online.
Submit to: firstname.lastname@example.org
To expedite the process, a TRAQ DSS will only be required for successful applications.
Release of funds will be subject to all usual certifications and approvals, including from all applicable hospitals.
An expedited Ethics Clearance process will be available, where applicable.
Notice to Associate Deans Research:
In the absence of the TRAQ DSS approval process, Associate Deans Research will be provided with the names of all Principal Investigators and Co-Investigators.
Please send all questions to email@example.com